ロード中...
New strategies for cancer immunotherapy: targeting regulatory T cells
The immunosuppressive action of regulatory T (T(reg)) cells is one mechanism attributed to the limited success of cancer immunotherapies with checkpoint blockers. Two recent studies report distinct transcriptional profiles of tumor-infiltrating T(reg) cells and expression of specific molecules, sugg...
保存先:
| 出版年: | Genome Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5273791/ https://ncbi.nlm.nih.gov/pubmed/28129791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-017-0402-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|